Exchange: NYSE·Updated 07:59 PM EDT

MDT News

News
all
press releases
BSX vs. MDT: Which Electrophysiology Stock Is the Better Bet Now?
Boston Scientific faces near-term pressure in electrophysiology, while Medtronic gains share and sees stronger momentum across key franchises.
Zacks
More News
Medtronic announces FDA clearance for LigaSure RAS Maryland instrument on the Hugo RAS system
Medtronic announces FDA clearance for LigaSure RAS Maryland instrument on the Hugo RAS system Medtronic announces FDA clearance for LigaSure RAS Maryland instrument on the Hugo RAS systemPR NewswireGALWAY, Ireland, Sept. 16, 2026 Trusted vessel-sealing technology used in more than 45 million...
PR Newswire
Boston Scientific Leans on Acquisitions to Drive Long-Term Growth
BSX's deal-making push expands its reach into high-growth markets, with Penumbra adding a major thrombectomy opportunity.
Zacks
MiniMed Files Form S-4 Registration Statement in Connection with Medtronic Exchange Offer Announcement
MiniMed Files Form S-4 Registration Statement in Connection with Medtronic Exchange Offer Announcement MiniMed Files Form S-4 Registration Statement in Connection with Medtronic Exchange Offer AnnouncementPR NewswireNORTHRIDGE, Calif., Sept. 14, 2026 NORTHRIDGE, Calif., Sept. 14, 2026 /PRNewswire...
PR Newswire
Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc.
Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc. Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc.PR NewswireGALWAY, Ireland, Sept. 14, 2026 Medtronic shareholders can exchange their Medtronicordinary shares for shares of MiniMedProvides...
PR Newswire
Two Medical Device Dividend Giants, One Better Buy: Medtronic vs. Abbott
Two Medical Device Dividend Giants, One Better Buy: Medtronic vs. Abbott...
Yahoo! Finance: News
These Two Healthcare Stocks Hit Key Milestones Today – Why Is Wall Street Bullish On Them?
Orchestra BioMed received an upgrade from BTIG while LifeStance Health Group received a price target hike from Barclays.
Stocktwits
Jim Cramer Calls Medtronic (MDT) a "Quandary" as Growth Surges and Diabetes Exit Nears
Jim Cramer Calls Medtronic (MDT) a "Quandary" as Growth Surges and Diabetes Exit Nears...
Yahoo! Finance: News
Medtronic Is on the Cusp of Becoming a Dividend King. Is the Stock a Buy for Income Investors?
Key PointsFactors such as the prospect of slow dividend growth could make Medtronic stock less attractive to income-focused investors...
Nasdaq News: Markets
Medtronic Raises 2027 Outlook as Broad-Based Growth Gains Momentum
MDT lifts its 2027 outlook as broad-based growth accelerates, but margin pressure and competition could test momentum.
Zacks

Advertisement|Remove ads.